With three of the awards won by graduates of the BioCity Accelerator. The winning businesses came from 37 multisector finalists, shortlisted from 289 applicants, who pitched their business idea live at Glasgow’s Technology and Innovation Centre and Edinburgh’s RBS Conference Centre on 28th and 30th May...
Oxford, UK – 2nd July 2019 Oxford Vacmedix UK Limited (OVM), the UK-based biopharma company focused on the development of cancer vaccines, announced today the award of an Innovate UK grant to CHAIN Biotechnology Ltd (CHAIN) and the University of Oxford to develop live biotherapeutics that...
BioAscent Discovery Limited has announced a three-fold increase in revenues during 2018, with projections on-track for a further 2.5-fold increase in 2019. These significant results have been driven by substantial contract wins for both BioAscent’s established compound management services and its newer integrated drug discovery offering....
XenoGesis Founder and CEO, Richard Weaver, has been named Director of the Year at the Institute of Directors East Midlands Awards 2019, in the SME business (Small) category. Held at Winstanley House, Leicestershire, the awards celebrated the most dynamic and inspiring directors in the region. Forty-six of...
AdamsonJones, a growing East-Midlands based firm of patent attorneys and trade mark attorneys, is pleased to announce that David Gwilliam, Eilidh Pugh and Jenny Vaughan have all been promoted to the position of Partner. These new promotions strengthen the firm’s life sciences team, an area of...
Innovative biotech start-up, Deep Branch Biotechnology, is partnering with Drax Group on a new bioenergy carbon capture usage and storage (BECCUS) pilot which could help reduce emissions from the agricultural sector Carbon dioxide will be used to create protein which could replace soy...
Medical technology businesses in the South East Midlands can apply to cover 50% of their clinical evaluation costs, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF) and the East Midlands Academic Health Science Network (EMAHSN). Grants...
Business support is now available for life science companies in the South East Midlands, thanks to a project delivered by Medilink East Midlands and part-funded by the European Regional Development Fund (ERDF). ACTIS is a £2.1 million scheme, part-funded by ERDF, to provide support for eligible...
Platelet specialists Dr Natalia Dovlatova, Ann White and Bob Humphries announce the launch of their new company – ‘Platelet Services Limited’, which will be based in BioCity Nottingham, UK. Collectively, the team has decades of experience in the application of platelet function testing to drug...
Nottingham, UK – 29 May 2019 Sygnature Discovery, a leading drug discovery and pre-clinical services company, have appointed Dr Nick Moore as Senior Director, Business Development, in a newly-created role to promote the in vivo pharmacology and consultancy services offered by RenaSci, a wholly-owned subsidiary...